Biotechnology News

February 20, 2013

LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology and the FDA Agree on an SPA for the Phase III trial of PB272 (neratinib) in HER2-positive metastatic breast cancer patients who have failed two or more prior treatments.

February 20, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer, today announced that Martin D. Williams, president and chief executive officer, is scheduled to...

February 20, 2013

SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ: CELG) announced today that it has entered into an accelerated share repurchase (ASR) agreement with an investment bank to repurchase an aggregate of $600 million of the company’s common...

February 20, 2013

BELGRADE, Mont.--(BUSINESS WIRE)--Bacterin Pre-Announces 4Q12 Revenues

February 20, 2013

MORRISVILLE, N.C.--(BUSINESS WIRE)--SOV Therapeutics Inc. announces today that the FDA has granted Orphan Drug Designation for the use of oral testosterone undecanoate in the treatment of CDGP in adolescent boys (14-17 years of age).

February 20, 2013

SAN CARLOS, Calif.--(BUSINESS WIRE)--Natera, a leading innovator in reproductive and prenatal genetic testing, today announced that the company’s non-invasive prenatal screening test, Panorama™, will launch on March 1 for the detection of trisomy...

February 20, 2013

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--The first Theorem Think Tank on drug development will be held in Boston from 3-7 p.m., March 7.

February 20, 2013

NASHVILLE, Tenn.--(BUSINESS WIRE)--Diagnovus, LLC, launched the first commercial gene expression assay that can aid physicians in better risk stratification and treatment of patients with diffuse large B-cell lymphoma (DLBCL).

February 20, 2013

BOULDER, Colo.--(BUSINESS WIRE)--A new study published in the Journal of Thoracic Oncology concludes that Biodesix’ VeriStrat test was predictive of survival outcomes between erlotinib and gemcitabine for elderly lung cancer patients

February 20, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zalicus granted key patent with broad coverage for Z944 including compositions of matter and certain therapeutic methods of use through April 2029.

February 20, 2013

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq:INCY) announced today it will present at the following investor conferences during the month of March: Cowen and Company’s 33rd Annual Health Care Conference on Wednesday, March 6,...

February 20, 2013

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Gynesonics Completes $21 Million Series D Financing. Financing Validates the attractiveness of VizAblate®

February 20, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Verastem will present on its PI3K inhibitor program at Keystone Symposia on “PI3-Kinase and Interplay with Other Signaling Pathways” being held February 24 - March 1, 2013, in Keystone, Colorado.

February 20, 2013

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. today announced its fourth-quarter and full-year 2012 results.

February 20, 2013

WHITEHOUSE STATION, N.J. & SEOUL, South Korea--(BUSINESS WIRE)--Merck, (NYSE: MRK) known as MSD outside the United States and Canada, and Samsung Bioepis Co., Ltd., entered into an agreement to develop and commercialize multiple pre-specified...

February 20, 2013

BURLINGTON, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ: DYAX) announced today that executive management will participate in two upcoming conferences, providing a corporate update regarding the Company’s key value drivers – the KALBITOR® (...

February 20, 2013

MANSFIELD, Mass.--(BUSINESS WIRE)--Covidien, a leading global provider of healthcare products, today announced the completion of patient enrollment in its iliac stent clinical study series...

February 20, 2013

EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Paul K. Wotton, Ph.D., President and Chief Executive Officer, will participate in the RBC Capital Markets’ Healthcare Conference on Wednesday, February 27,...

February 20, 2013

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals to present corporate update at the RBC Capital Markets Healthcare Conference in New York on February 27th

February 20, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVEO Oncology (NASDAQ: AVEO) today announced that David Johnston, chief financial officer, is scheduled to present at the 2013 RBC Capital Markets’ Healthcare Conference on Wednesday, February 27, 2013 at 2:00 p...

February 20, 2013

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced that it will webcast the Company’s presentation at the Cowen and Company 33rd Annual Health Care Conference in Boston, Massachusetts on March 6, 2013. The live webcast is...

February 20, 2013

TEL AVIV, Israel--(BUSINESS WIRE)--Compugen Ltd. (NASDAQ: CGEN) today reported financial results for the fourth quarter and year ended December 31, 2012 and disclosed its primary objectives for 2013. Dr. Anat Cohen-Dayag, president and CEO of...

February 20, 2013

SHEFFIELD, England--(BUSINESS WIRE)--Simcyp Adds a Pregnancy Model to its Population-Based Simulator and Includes a Scripting Facility for Customising Pharmacodynamic Response Models

February 20, 2013

RAVENSBURG, Germany--(BUSINESS WIRE)--Vetter, one of the worlds’ leading Contract and Development Manufacturing Organization, will present on a variety of informative core developments at the 15th Pharma Congress in Düsseldorf.

February 20, 2013

ZURICH & BARCELONA, Spain--(BUSINESS WIRE)--High attendance by pharma and biotech investors and venture capital firms is expected at BIO-Europe Spring® 2013 in Barcelona, Spain, March 11–13.

February 20, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Inspiration Biopharmaceuticals announce closing of IB1001 sale to Cangene Corporation. Sale process for all assets is complete with total aggregate consideration potentially in excess of USD1 billion

February 20, 2013

PARIS--(BUSINESS WIRE)--Regulatory News: Ipsen (Paris:IPN) (Euronext: IPN; ADR: IPSEY) and Inspiration Biopharmaceuticals Inc. (Inspiration) today announced the closing of the sale of the proprietary hemophilia B product, IB1001 (recombinant FIX...

February 20, 2013

HUBBARD, Ohio--(BUSINESS WIRE)--NanoLogix Inc. (OTC: NNLX), the biotechnology company focused primarily on rapid diagnostics, is pleased to announce independent tests show extraordinary success in testing of a revolutionary new packaging...

February 20, 2013

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that Gilead and Teva Pharmaceuticals have reached an agreement in principle to settle the ongoing patent litigation concerning the patents protecting...

February 19, 2013

BETHESDA, Md.--(BUSINESS WIRE)--Sucampo Announces Commercial Availability of RESCULA® in U.S. Pharmacies

February 19, 2013

SANTA CLARA, Calif.--(BUSINESS WIRE)--XenoPort, Inc. (Nasdaq: XNPT) announced today that it will provide access via the World Wide Web to its presentations at the RBC and Citigroup 2013 Healthcare Conferences. The live presentations will occur at...

February 19, 2013

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb to Take Part in Citi 2013 Global Health Care Conference.

February 19, 2013

DUBLIN--(BUSINESS WIRE)--Alkermes plc (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live at the Citi 2013 Global Healthcare Conference on Monday, Feb. 25, 2013, at 11:05 a.m. EST (4:05 p.m. GMT) from the Hilton...

February 19, 2013

LOS ANGELES--(BUSINESS WIRE)--KYTHERA Biopharmaceuticals, Inc. (NASDAQ: KYTH) today announced that Keith Leonard, President and Chief Executive Officer, will present at the 2013 RBC Global Healthcare Conference in New York. Event:   2013 RBC...

February 19, 2013

NASHUA, N.H.--(BUSINESS WIRE)--iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today reported financial results for...

February 19, 2013

WESTON, Mass.--(BUSINESS WIRE)--Biogen Idec Inc. (NASDAQ: BIIB) announced today that it will present at the Citi 2013 Global Healthcare Conference. The webcast will be live on Monday, February 25, 2013 at 1:30p.m. ET. To access the live webcast,...

February 19, 2013

BIRMINGHAM, Ala.--(BUSINESS WIRE)--BioDtech, Inc., a biotechnology company engaged in the development of cutting-edge products for the endotoxin market, announced that it has been granted a patent.

February 19, 2013

BOSTON & GENEVA--(BUSINESS WIRE)--Jonathan S. Helfgott, FDA Compliance Officer for CDER within the office of Scientific Investigations will present at the U.S. PRO & eCOA Congress hosted by PHT Corporation, March 26-28, Baltimore.

February 19, 2013

CLEVELAND--(BUSINESS WIRE)--The Healthcare Information and Management Systems Society, known as HIMSS, will lease 25,000 square feet of newly-renamed Global Center for Health Innovation, formerly the Cleveland Medical Mart.

February 19, 2013

EXTON, Pa.--(BUSINESS WIRE)--Fibrocell Science, Inc. announced today that it has initiated a study to evaluate a new autologous skin care crème to assess the impact of the crème on mild to severe photo-damaged skin.

February 19, 2013

SOMERSET, N.J.--(BUSINESS WIRE)--Alliance Life Sciences Offers Robust Aggregate Spend Program Strategy for Federal and State Sunshine Act Compliance Readiness

February 19, 2013

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. invites investors and the general public to listen to a webcast of a discussion with Geno Germano, President and General Manager, Specialty Care and Oncology, at the Citi 2013 Global Healthcare Conference on...

February 19, 2013

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today introduced an expanded line of analytical solutions designed for on-site field use, providing immediate laboratory-quality measurements of a wide variety of samples....

February 19, 2013

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the following webcasts for the investment community: Agilent Technologies 2013 Analyst Meeting Thursday, March 7, 2013, at 8:30 a.m. ETNYSE Euronext, New...

February 19, 2013

IRVINE, Calif.--(BUSINESS WIRE)--Presbia, a medical device company and leader in near vision restoration, announced today the appointment of Jake Vander Zanden as Chief Commercial Officer. Bringing more than 25 years of experience in the...

February 19, 2013

WASHINGTON--(BUSINESS WIRE)--AAFS Recognizes Award-Winning Forensic Toxicologists of NMS Labs